From July 1, 2022 to July 12, 2022, the company has repurchased 358,700 shares, representing 0.06% for CNY 10.41 million. With this, the company has completed the repurchase of 2,942,813 shares, representing 0.5% for CNY 119.97 million under the buyback announced on March 18, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.07 CNY | +1.44% | +4.04% | -2.46% |
Feb. 29 | Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84% | MT |
Feb. 28 | Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.46% | 1.48B | |
+0.89% | 12.59B | |
-10.29% | 7.42B | |
+1.78% | 5.35B | |
-1.16% | 4.51B | |
+5.63% | 4.47B | |
-50.77% | 3.21B | |
+12.21% | 2.71B | |
-16.13% | 1.96B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- 688289 Stock
- News Sansure Biotech Inc.
- Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on March 18, 2022.